What is FluoroFinder?
FluoroFinder specializes in creating an AI-driven platform designed to streamline the design of fluorescence experiments. The company's suite of tools addresses critical needs in the life sciences, offering solutions for flow cytometry panel design, antibody searches, and access to a comprehensive fluorescent dye database. By simplifying experiment planning and reducing potential errors, FluoroFinder empowers researchers across various applications, including flow cytometry, ELISA, and immunofluorescence. The platform aggregates over 3 million products from more than 78 suppliers, providing a flexible and optimized environment for scientific inquiry. Its established reputation is built on trust from institutions globally, positioning FluoroFinder as a key resource for advancing biological research.
How much funding has FluoroFinder raised?
FluoroFinder has raised a total of $4.4M across 2 funding rounds:
Debt
$1M
Private Equity
$3.4M
Debt (2014): $1M, investors not publicly disclosed
Private Equity (2016): $3.4M, investors not publicly disclosed
What's next for FluoroFinder?
The recent major strategic investment signifies a crucial phase for FluoroFinder, likely indicating a move towards scaling operations and expanding its market reach. This capital injection, following substantial prior funding rounds, suggests the company is poised for significant growth and further innovation in its AI-powered experimental design solutions. FluoroFinder's focus on simplifying complex fluorescence experiments positions it to capture a larger share of the life sciences research market, potentially leading to new product developments and strategic partnerships aimed at enhancing research efficiency and discovery worldwide.
See full FluoroFinder company page
